NCT02720874Withdrawn
Multidisciplinary Approach for Treat To Target In Rheumatoid Arthritis
Multidisciplinary Approach to Patient-Physician Partnership In Treating To Target In Rheumatoid Arthritis
Source: ClinicalTrials.gov · Last updated 2 Jul 2026
Reason given: Terminated due to several programmatic delays such as personnel transitions and departures, challenges to replace them as specified in the protocol, and delays due to COVID-19 pandemic-related institutional closures and clinical research pauses.
Brief summary (registry, in English)
This research will evaluate a multifaceted patient-centered intervention in a sample of socioeconomically disadvantaged Hispanic adults with rheumatoid arthritis (RA) that capitalizes on a partnership between the extended rheumatology healthcare team and each patient in order to promote understanding, uptake and adherence to the principles of treat-to-target strategy. The primary hypothesis of this study is that the addition of a multifaceted intervention incorporating integrated multidisciplinary rheumatologic care, nurse-directed self-management education and supportive follow-up, and technology-based at home RA symptom monitoring and reporting to clinical guideline-based care will increase RA remission rate at 6 months.
- Status (registry)
- Withdrawn
- Study type
- Interventional
- Enrollment
- 0 (actual)
- First submitted
- 22 Mar 2016
- Start date
- 1 Jan 2025
- Primary completion date
- 14 Apr 2025
- Lead sponsor
- Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center
- Diseases
- Rheumatoid arthritis
- NCT number
- NCT02720874
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Overlapping autoimmune or mixed connective tissue syndromes
- Serious medical conditions, including: chronic infection, advanced or decompensated heart failure, higher than class II chronic kidney disease, cancer (unless in remission for period of 5 years or more), or any uncontrolled medical condition that is deemed by the investigators to interfere with the study protocol
Other
- Known irreversible articular damage, including subluxations, arthrodesis, fusion, or prosthesis
- Functional class IV as defined by the American College of Rheumatology Classification of Functional Status in rheumatoid arthritis
- At risk for suicide
Who the study is looking for
- Reside in Greater Los Angeles area and receive rheumatologic care at the adult rheumatology clinic at Harbor-UCLA Medical Center in Torrance, California
- Fulfill the 2010 American College of Rheumatology revised diagnostic criteria for RA
- Have at least moderate disease activity as indicated by a Clinical Disease Activity Index (CDAI) score >10 and Routine Assessment Patient Index Data (RAPID3) score >2
- Be able and willing to provide written informed consent and to adhere to the study visit schedule and other protocol
- Availability of a touch-tone landline or mobile telephone
- Of self-identified Hispanic/Latino descent
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| The Lundquist Institute at Harbor UCLA Medical Center | Torrance | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.